Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy

Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy

Nanomedicines have shown great potential in cancer therapy; in particular, the combination of chemotherapy and immunotherapy (namely chemoimmunotherapy) that is revolutionizing cancer treatment. Currently, most nanomedicines for chemoimmunotherapy are still in preclinical and clinical trials. Lipid-...

Full description

Bibliographic Details
Main Authors: Tianqi Wang, Yusuke Suita, Saradha Miriyala, Jordan Dean, Nikos Tapinos, Jie Shen
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceutics
Subjects:
chemoimmunotherapy
lipid-based nanoparticles
liposomes
cancer therapy
immunotherapy
Online Access:https://www.mdpi.com/1999-4923/13/4/520

Internet

https://www.mdpi.com/1999-4923/13/4/520

Similar Items